ArticleBMC infectious diseases2026
Targeting carbapenem-resistant and hypervirulent Klebsiella pneumoniae: in vitro evaluation of cefepime/zidebactam, aztreonam/avibactam, imipenem/relebactam, and meropenem/vaborbactam.
Yi Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.